![Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | FiercePharma Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | FiercePharma](https://qtxasset.com/styles/breakpoint_sm_default_480px_w/s3/fiercepharma/1632929496/Inhaler%20Tales%20Carousel%20Mock%20on%20Tevausa_R2_OP1%20%28003%29.jpg?VersionId=Z8pwr5m8SiBQ3u.6Qa0yt6ZaXLLDlFf_&itok=Yf3wccnz)
Buffy the asthma inhaler? Teva taps 'Vampire Slayer' actress to raise inhaler misuse awareness | FiercePharma
Teva Pharmaceuticals USA - Teva is proud to support the #asthma patient community by providing an unrestricted education grant to Asthma and Allergy Foundation of America (AAFA), to help publish this special
![Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America](https://community.aafa.org/fileSendAction/fcType/0/fcOid/510642830861510679/filePointer/510642830861510701/fodoid/510642830861510696/imageType/MEDIUM/inlineImage/true/Teva-announced-launch-of-new-daily-asthma-medicine.png)
Teva Pharmaceuticals Announces Launch of Daily Maintenance Asthma Medication | Asthma and Allergy Foundation of America
![Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder](https://mms.businesswire.com/media/20200921005170/en/819864/4/Interactive_Media_Placeholder_webready.jpg)
Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder
![Teva Pharmaceuticals on Twitter: "#DYK: #Asthma costs the United States $56 billion each year. #ACAAI16… " Teva Pharmaceuticals on Twitter: "#DYK: #Asthma costs the United States $56 billion each year. #ACAAI16… "](https://pbs.twimg.com/media/Cw_W05iUoAAN4-t.jpg)
Teva Pharmaceuticals on Twitter: "#DYK: #Asthma costs the United States $56 billion each year. #ACAAI16… "
![Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena](https://www.clinicaltrialsarena.com/wp-content/uploads/sites/22/2019/07/1l-image-113.jpg)
Cinqair (reslizumab) Injection for treatment of Severe Asthma and an Eosinophilic Phenotype - Clinical Trials Arena
![Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times](https://static01.nyt.com/images/2019/05/11/business/11xp-teva2/11xp-teva2-superJumbo.jpg)
Teva and Other Generic Drugmakers Inflated Prices Up to 1,000%, State Prosecutors Say - The New York Times
![Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com](https://media.snacksafely.com/wp-content/uploads/2019/07/Digihaler-1068x559.jpg)
Teva Announces FDA Approval of First and Only Digital Inhaler with Built-In Sensors – ProAir® Digihaler™ | SnackSafely.com
![Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire Teva Canada Announces Availability of Aermony RespiClick™, an Innovative New Device for the Treatment of Bronchial Asthma | Business Wire](https://mms.businesswire.com/media/20201005005212/en/826961/5/AermonyRespiClick_ENG.jpg)